Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | AGXT | P21549 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL400236 | 0.93 | IDO1 (0.46) | IDO1TSHRTRPA1ALDH1A1TAAR1 | |
| SCHEMBL13973047 | 0.87 | ACHE (0.40) | IDO1TSHRTRPA1ALDH1A1CYP3A4 | |
| SCHEMBL8447346 | 0.87 | IDO1 (0.33) | IDO1TSHRTRPA1ALDH1A1 | |
| SCHEMBL331501 | 0.86 | TRPA1 (0.47) | TSHRTRPA1ALDH1A1 | |
| SCHEMBL24661052 | 0.81 | IDO1 (0.38) | IDO1TSHRTRPA1ALDH1A1TAAR1 | |
| SCHEMBL10448080 | 0.81 | IDO1 (0.33) | IDO1TSHRTRPA1ALDH1A1 | |
| SCHEMBL29999249 | 0.81 | TSHR (0.40) | IDO1TSHRTRPA1ALDH1A1CYP3A4 | |
| SCHEMBL30349373 | 0.81 | TACR1 (0.41) | IDO1TSHRTRPA1ALDH1A1 | |
| SCHEMBL29472374 | 0.81 | IDO1 (0.34) | IDO1TSHRTRPA1ALDH1A1 | |
| SCHEMBL305652 | 0.81 | TACR1 (0.41) | IDO1TSHRTRPA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103570483-A | Preparation method for 3, 5-dithienylethene benzaldehyde | UNIV JINAN | 2014-02-12 | — | — | CN | claimed |
| EP-4636054-A2 | NARROW EMISSION DYES, COMPOSITIONS COMPRISING SAME, AND METHODS FOR MAKING AND USING SAME | NIRvana Sciences Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-3959292-B1 | NARROW EMISSION DYES, COMPOSITIONS COMPRISING SAME, AND METHODS FOR MAKING AND USING SAME | NIRVANA SCIENCES INC (US) | 2025-07-02 | — | — | EP | disclosed |
| WO-2025082283-A1 | LIGAND COMPOUND OF CYCLOPEPTIDE STRUCTURE, NUCLIDE MARKER THEREOF, PHARMACEUTICAL COMPOSITION, AND USE | 四川科伦博泰生物医药股份有限公司 | 2025-04-24 | — | — | WO | disclosed |
| CN-119752217-A | Narrow emission dyes, compositions comprising the same, and methods of making and using the same | 尼尔瓦纳科学股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-114222803-B | Narrow emission dyes, compositions comprising the same, and methods of making and using the same | 尼尔瓦纳科学股份有限公司 | 2025-01-07 | — | — | CN | disclosed |
| EP-3959293-B1 | NARROW EMISSION DYES, COMPOSITIONS COMPRISING SAME, AND METHODS FOR MAKING AND USING SAME | NIRVANA SCIENCES INC (US) | 2024-11-13 | — | — | EP | disclosed |
| US-20220249708-A1 | NARROW EMISSION DYES, COMPOSITIONS COMPRISING SAME, AND METHODS FOR MAKING AND USING SAME | NIRVANA SCIENCES INC. (US) | 2022-08-11 | — | — | US | disclosed |
| US-20220249707-A1 | NARROW EMISSION DYES, COMPOSITIONS COMPRISING SAME, AND METHODS FOR MAKING AND USING SAME | NIRVANA SCIENCES INC. (US) | 2022-08-11 | — | — | US | disclosed |
| CN-114222802-A | Narrow emission dyes, compositions comprising the same, and methods of making and using the same | 尼尔瓦纳科学股份有限公司 | 2022-03-22 | — | — | CN | disclosed |
| EP-1189609-A1 | CXCR-4 RECEPTOR ANTAGONISTS - THROMBOPOIETIN MIMETICS | SMITHKLINE BEECHAM CORPORATION (US) | 2002-03-27 | — | — | EP | disclosed |
| WO-2001000578-A1 | 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF | MERCK & CO., INC. (US) | 2001-01-04 | — | — | WO | disclosed |
| WO-2000066112-A1 | CXCR-4 RECEPTOR ANTAGONISTS - THROMBOPOIETIN MIMETICS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-11-09 | — | — | WO | disclosed |
| EP-0707624-B1 | PERFLUORO-1H-1H-NEOPENTYL CONTAINING CONTRAST AGENTS AND METHOD TO USE SAME | MOLECULAR BIOSYSTEMS INC (US) | 2000-05-10 | — | — | EP | disclosed |
| US-5877214-A | Polyaryl-poly(ethylene glycol) supports for solution-phase combinatorial synthesis | MERCK & CO., INC. (US) | 1999-03-02 | — | — | US | disclosed |
| WO-1996015134-A1 | L-α-AMINO-3-BIPHENYL-PROPANOIC ACID DERIVATIVE | NOVARTIS AG (CH) | 1996-05-23 | — | — | WO | disclosed |
| EP-0707624-A1 | PERFLUORO-1H-1H-NEOPENTYL CONTAINING CONTRAST AGENTS AND METHOD TO USE SAME | MOLECULAR BIOSYSTEMS, INC. (US) | 1996-04-24 | — | — | EP | disclosed |
| EP-0707624-A4 | PERFLUORO-1H-1H-NEOPENTYL CONTAINING CONTRAST AGENTS AND METHOD TO USE SAME | MOLECULAR BIOSYSTEMS INC (US) | 1996-02-29 | — | — | EP | disclosed |
| US-5401493-A | Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same | MOLECULAR BIOSYSTEMS, INC. (US) | 1995-03-28 | — | — | US | disclosed |
| WO-1994022368-A1 | PERFLUORO-1H-1H-NEOPENTYL CONTAINING CONTRAST AGENTS AND METHOD TO USE SAME | MOLECULAR BIOSYSTEMS, INC. (US) | 1994-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220249707-A1 | NARROW EMISSION DYES, COMPOSITIONS COMPRISING SAME, AND METHODS FOR MAKING AND USING SAME | AQP4, CLSPN, CHLSN | IDO1 2350/4885TSHR 1806/4885TRPA1 2454/4885 |
| US-20220249708-A1 | NARROW EMISSION DYES, COMPOSITIONS COMPRISING SAME, AND METHODS FOR MAKING AND USING SAME | MB, LNPEP, BCR | IDO1 1621/4885TSHR 3247/4885TRPA1 2467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.